N Aymard

410 total citations
31 papers, 332 citations indexed

About

N Aymard is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Physiology. According to data from OpenAlex, N Aymard has authored 31 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Biological Psychiatry and 6 papers in Physiology. Recurrent topics in N Aymard's work include Bipolar Disorder and Treatment (8 papers), Schizophrenia research and treatment (7 papers) and Tryptophan and brain disorders (6 papers). N Aymard is often cited by papers focused on Bipolar Disorder and Treatment (8 papers), Schizophrenia research and treatment (7 papers) and Tryptophan and brain disorders (6 papers). N Aymard collaborates with scholars based in France, Canada and New Zealand. N Aymard's co-authors include Marie‐France Poirier, Bernard Mazoyer, André Syrota, A Féline, M.H. Dao-Castellana, Jean‐Luc Martinot, D. Attar-Lèvy, Marie‐Chantal Bourdel, J. Blin and C. Crouzel and has published in prestigious journals such as Biological Psychiatry, International Journal of Obesity and Life Sciences.

In The Last Decade

N Aymard

29 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N Aymard France 11 95 81 56 47 40 31 332
F. Flentge Netherlands 10 97 1.0× 39 0.5× 57 1.0× 34 0.7× 33 0.8× 17 374
Richard T Owen United Kingdom 12 92 1.0× 103 1.3× 79 1.4× 54 1.1× 47 1.2× 36 364
Jerry Oliver United States 10 135 1.4× 136 1.7× 56 1.0× 40 0.9× 35 0.9× 13 453
H.C. Stancer Canada 12 123 1.3× 88 1.1× 33 0.6× 25 0.5× 39 1.0× 24 446
Stephen G. Molyneux United Kingdom 8 183 1.9× 60 0.7× 38 0.7× 17 0.4× 51 1.3× 8 346
Leon Lombrozo United States 10 114 1.2× 130 1.6× 57 1.0× 27 0.6× 21 0.5× 18 346
Tetsuhiko Kariya Japan 9 117 1.2× 140 1.7× 40 0.7× 68 1.4× 75 1.9× 23 435
Rocco Raffaele Italy 13 193 2.0× 111 1.4× 61 1.1× 53 1.1× 45 1.1× 22 568
Maria J. Sarrias Spain 9 176 1.9× 103 1.3× 84 1.5× 18 0.4× 55 1.4× 9 406
G Allers France 11 188 2.0× 144 1.8× 140 2.5× 37 0.8× 30 0.8× 24 449

Countries citing papers authored by N Aymard

Since Specialization
Citations

This map shows the geographic impact of N Aymard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Aymard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Aymard more than expected).

Fields of papers citing papers by N Aymard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Aymard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Aymard. The network helps show where N Aymard may publish in the future.

Co-authorship network of co-authors of N Aymard

This figure shows the co-authorship network connecting the top 25 collaborators of N Aymard. A scholar is included among the top collaborators of N Aymard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Aymard. N Aymard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Selmaoui, Brahim, et al.. (2003). Evaluation of the nocturnal levels of urinary biogenic amines in men exposed overnight to 50-Hz magnetic field. Life Sciences. 73(24). 3073–3082. 7 indexed citations
2.
Aymard, N, et al.. (2002). Long-term pharmacoclinical follow-up in schizophrenic patients treated with risperidone. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(5). 975–988. 11 indexed citations
3.
Smirnova, Maria, et al.. (2001). Influence of social isolation and 6-OHDA lesion on the effects of quinelorane. Pharmacology Biochemistry and Behavior. 69(1-2). 143–149. 2 indexed citations
4.
5.
Attar-Lèvy, D., Jean‐Luc Martinot, J. Blin, et al.. (1999). The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine. Biological Psychiatry. 45(2). 180–186. 91 indexed citations
6.
Tounian, Patrick, et al.. (1999). Weight loss and changes in energy metabolism in massively obese adolescents. International Journal of Obesity. 23(8). 830–837. 30 indexed citations
7.
Galinowski, A., et al.. (1998). Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol. Acta Psychiatrica Scandinavica. 97(6). 458–466. 6 indexed citations
8.
Pham‐Huy, Chuong, Hervé Galons, Nourédine Sadeg, et al.. (1997). Enantioselective high-performance liquid chromatography determination of methadone enantiomers and its major metabolite in human biological fluids using a new derivatized cyclodextrin-bonded phase. Journal of Chromatography B Biomedical Sciences and Applications. 700(1-2). 155–163. 41 indexed citations
9.
Aymard, N, et al.. (1996). [Pharmaco-clinical correlations during fluoxetine administration in patients with depressive schizophrenia treated with haloperidol decanoate].. PubMed. 51(1). 19–25. 5 indexed citations
10.
11.
Henrotte, J. G., et al.. (1995). Effect of Pyridoxine and Magnesium on Stress-Induced Gastric Ulcers in Mice Selected for Low or High Blood Magnesium Levels. Annals of Nutrition and Metabolism. 39(5). 285–290. 11 indexed citations
12.
Aymard, N, et al.. (1994). Determination of 5-hydroxytryptamine and tryptophan by liquid chromatography in whole blood. Its interest for the exploration of mental disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 18(1). 77–86. 15 indexed citations
13.
Henrotte, J. G., et al.. (1993). Brain weight and noradrenaline content in mice selected for low (MGL) and high (MGH) blood magnesium.. PubMed. 6(1). 21–4. 7 indexed citations
14.
Traiffort, Élisabeth, et al.. (1991). Rapid determination of 5-hydroxytryptamine in whole blood by liquid chromatography with fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 571(1-2). 231–234. 11 indexed citations
15.
Rondot, Pierre, et al.. (1989). Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.. PubMed. 39(11 Suppl 2). 74–7; discussion 95. 10 indexed citations
16.
Rondot, Pierre, M. Ziégler, N Aymard, & J. Holzer. (1987). Clinical Trial of Madopar HBS in Parkinsonian Patients with Fluctuating Drug Response after Long-Term Levodopa Therapy. European Neurology. 27(1). 114–119. 6 indexed citations
17.
Soulairac, A & N Aymard. (1977). [Circadian rhythm of plasma cortisol in chronic mental alcoholism].. PubMed. 2(2). 317–22. 2 indexed citations
18.
Soulairac, A, et al.. (1976). [Action of the serotonin precursor, 5-hydroxy-tryptophan, on aggressive symptomology].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(3). 459–63. 4 indexed citations
19.
Reinberg, Alain, et al.. (1975). [Circadian variations of the effects of ethanol and of blood ethanol values in the healthy adult man. Chronopharmacological study].. PubMed. 70(4). 435–56. 15 indexed citations
20.
Soulairac, A & N Aymard. (1972). [Changes in blood and urinary electrolytes during treatment with lithium salts].. PubMed. 1(2). 257–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Flentge Breakdown of academic impact, for papers by Richard T Owen Breakdown of academic impact, for papers by Jerry Oliver Breakdown of academic impact, for papers by H.C. Stancer Breakdown of academic impact, for papers by Stephen G. Molyneux Breakdown of academic impact, for papers by Leon Lombrozo Breakdown of academic impact, for papers by Tetsuhiko Kariya Breakdown of academic impact, for papers by Rocco Raffaele Breakdown of academic impact, for papers by Maria J. Sarrias Breakdown of academic impact, for papers by G Allers
Rankless by CCL
2026